Results 181 to 190 of about 5,262,931 (244)

Patient-Derived Organoid Models for NKT Cell-Based Cancer Immunotherapy. [PDF]

Cancers (Basel)
Palacios PA, Flores I, Cereceda L, Otero FF, Müller M, Brebi P, Contreras HR, Carreño LJ.   +7 more
europepmc   +1 more source

CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma. [PDF]

Br J Cancer
Strassheimer F, Elleringmann P, Ludmirski G, Roller B, Macas J, Alekseeva T, Cakmak P, Aliraj B, Krenzlin H, Demes MC, Mildenberger IC, Tonn T, Weber KJ, Reiss Y, Plate KH, Weigert A, Wels WS, Steinbach JP, Burger MC.   +18 more
europepmc   +1 more source

Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment. [PDF]

mBio, 2021
Liu J, Yang X, Wang H, Li Z, Deng H, Liu J, Xiong S, He J, Feng X, Guo C, Wang W, Zelinskyy G, Trilling M, Sutter K, Senff T, Menne C, Timm J, Zhang Y, Deng F, Lu Y, Wu J, Lu M, Yang D, Dittmer U, Wang B, Zheng X.   +25 more
europepmc   +1 more source

Intratumoral NKT cell accumulation promotes antitumor immunity in pancreatic cancer. [PDF]

Proc Natl Acad Sci U S A
Li J, Moresco P, Fearon DT.
europepmc   +1 more source

HSV-1 UL56 protein recruits cellular NEDD4-family ubiquitin ligases to suppress CD1d expression and NKT cell function. [PDF]

J Virol
Qiu L, Gao X, Shao X, Xi J, Chen S, Pham T, Wang Y, Dong J, Rao SD, Hao J, Lo JH, Yang R, Engel EA, Crump CM, Yuan W.   +14 more
europepmc   +1 more source

PRDM1 Is a Key Regulator of the NKT-cell Central Memory Program and Effector Function. [PDF]

Cancer Immunol Res
Tian G, Barragan GA, Yu H, Martinez-Amador C, Adaikkalavan A, Rios X, Guo L, Drabek JM, Pardias O, Xu X, Montalbano A, Zhang C, Li Y, Courtney AN, Di Pierro EJ, Metelitsa LS.   +15 more
europepmc   +1 more source

Regulatory T cells induce CD4^- NKT cell anergy and suppress NKT cell cytotoxic function. [PDF]

Cancer Immunol Immunother, 2019
Ihara F, Sakurai D, Takami M, Kamata T, Kunii N, Yamasaki K, Iinuma T, Nakayama T, Motohashi S, Okamoto Y.   +9 more
europepmc   +1 more source

I39. NKT Cells [PDF]

Rheumatology, 2015
openaire   +1 more source

EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer. [PDF]

Technol Cancer Res Treat
Ye F, Yuan X, Yu W, Ma Y, Mao C, Li X, Li J, Dai C, Qian F, Li J, Fan X, Zhou Y, Dai D, Wang D, Chen D, Xia S, Zhang M.   +16 more
europepmc   +1 more source

NK and NKT Cell-Mediated Immune Surveillance against Hematological Malignancies. [PDF]

Cancers (Basel), 2020
Shimizu K, Iyoda T, Yamasaki S, Kadowaki N, Tojo A, Fujii AS.   +5 more
europepmc   +1 more source